The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prognostic impact of preoperative plasma tissue inhibitor of metalloproteinase 1 (pTIMP-1) in colorectal cancer (CRC) patients (Pts): A pooled analysis of 1,024 stage II/III pts.
Nils BrĂ¼nner
No relevant relationships to disclose
Qian Shi
No relevant relationships to disclose
Ib Jarle Christensen
No relevant relationships to disclose
Hans J. Nielsen
No relevant relationships to disclose
T Hendriks
No relevant relationships to disclose
Bengt Glimelius
No relevant relationships to disclose
Helgi Birgisson
No relevant relationships to disclose
Mads Holten-Andersen
No relevant relationships to disclose
Daniel J. Sargent
No relevant relationships to disclose